← Leaderboards
Marc Sharp
Linnaeus Bioscience, Inc.
$2,099,634
Attributed
$3,175,657
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $718.9K · FY2014–21$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,175,657 · 5
By mechanism
R01$2,152,047 · 1
R43$1,023,610 · 4
Top collaborators
- Karen Joy Shaw3 shared
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyBasePathogenAntifungal AgentsBiological SciencesCell WallInfectionGpi Membrane AnchorsInhibitor/AntagonistAntibioticsCandidiasisFee-For-Service PlansCandidaHourFluorescence MicroscopyCommunitiesCollectionCytotoxicityEffectivenessEnzymesAspergillusAspergillosisCellsDrug Industry
Grant awards (7)
Development of a new class of antifungals effective against Cryptococcus$714,554
R01 · FY2021 · AI · contact PI
Development of a new class of antifungals effective against Cryptococcus$718,597
R01 · FY2020 · AI · contact PI
Development of a new class of antifungals effective against Cryptococcus$718,896
R01 · FY2019 · AI · contact PI
Development of Image Based Profiling for Antifungal Discovery$300,000
R43 · FY2018 · AI · contact PI
Identification of macrocyclic molecules with antibacterial activity$300,000
R43 · FY2017 · AI · contact PI
Identification of novel natural products active against MDR pathogens$199,405
R43 · FY2015 · AT · contact PI
Development of a new image based technology to rapidly screen natural product ext$224,205
R43 · FY2014 · TR · contact PI